Abstracts


Abstract book
The abstract book is published as a supplement of The Breast (Volume 24, Supplement 3, November 2015) and contains abstracts of the invited lecturers and those submitted by the participants that have been accepted for oral or poster presentation or for publication only. The book was distributed on site to all registered participants. Please note, however, that some abstracts were part of the media coverage and therefore the content was embargoed till presented at the Conference (see below).

The abstract book, containing all abstracts, is available as a flip book HERE.

Embargoed abstracts
The following abstracts are part of the media coverage and are therefore embargoed till the provided date.

IN02
METAVIVOR: FIGHTING PREJUDICE
CJ (Dian) Corneliussen-James
Metavivor Research and Support Inc, Annapolis, USA
This abstract was embargoed till Thursday, 5 November, 00:01 CET. The embargo is now lifted and the abstract is available HERE.

IN05
LONG TERM SURVIVAL WITH ADVANCED DISEASE.  CHALLENGES FOR THE PATIENT, THEIR SUPPORT SYSTEM AND CARE GIVERS

Karen Gelmon (1,2), Sally Thorne (2)
(1) BC Cancer Agency, Medical Oncology Dpt., Vancouver, Canada
(2) University of British Columbia, Medical Oncology Dept, Vancouver, Canada
This abstract was embargoed till Thursday, 5 November, 00:01 CET. The embargo is now lifted and the abstract is available HERE. 

IN06
LIVING ON BORROWED TIME: LONG TERM RESPONDERS

Shirley A. Mertz
Metastatic Breast Cancer Network, New York, NY, USA
This abstract was embargoed till Thursday, 5 November, 00:01 CET. The embargo is now lifted and the abstract is available HERE.

BP129
INSULIN RESISTANCE (IR) AND PROGNOSIS OF METASTATIC BREAST CANCER (MBC) PATIENTS
Nicoletta Provinciali (4), Matteo Puntoni (4), Oriana Nanni (6), Paolo Bruzzi (5), Andrea DeCensi (4), Laura Paleari (4), Andrea Freschi (2), Laura Amaducci (3), Alessandra Bologna (1), Lorenzo Gianni (7), Andrea Rocca (6), Dino Amadori (6), Alessandra Gennari (4)
(1) Arcispedale “S. Maria Nuova” IRCCS, Medical Oncology Unit, Reggio Emilia, Italy
(2) Centro di Riferimento Oncologico, Oncologia Medica C, Aviano, Italy
(3) Degli Infermi Hospital, Oncology Unit, Faenza, Italy
(4) E.O. Ospedali Galliera, Division of Medical Oncology, Genoa, Italy
(5) IRCCS Azienda Ospedaliera Universitaria San Martino – Ist - Istituto Nazionale Per La Ricerca Sul Cancro, Clinical Epidemiology, Genoa, Italy
(6) IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Unit of Biostatistics and Clinical Trials, Meldola, Italy
(7) Ospedale Infermi, Division of Oncology, Rimini, Italy

This abstract was embargoed till Thursday, 5 November, 11:00 CET. The embargo is now lifted and the abstract is available HERE.

IN33
THE COST OF BREAST CANCER: A GLOBAL PERSPECTIVE

Richard Sullivan
Institute of Cancer Policy, King’s College London, King’s Health Partners Comprehensive Cancer Centre, Guy’s Hospital Campus, London, UK

This abstract was embargoed till Friday, 6 November, 00:01 CET. The embargo is now lifted and the abstract is available HERE.
 

IN34
BREAST CANCER CARE ACCESS AND AFFORDABILITY: ARE DRUGS THE MAIN ISSUE IN EUROPE?

David Taylor
University College London, Pharmaceutical and Public Health Policy Dept., London, UK

This abstract was embargoed till Friday, 6 November, 00:01 CET. The embargo is now lifted and the abstract is available HERE.